 Emily Bucholz
Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Readmission | 7 | 2022 | 607 | 2.520 |
Why?
| | Insurance, Health | 2 | 2023 | 243 | 1.330 |
Why?
| | Medicaid | 3 | 2022 | 404 | 1.190 |
Why?
| | Hospitals, Pediatric | 3 | 2022 | 478 | 1.180 |
Why?
| | Myocardial Infarction | 5 | 2016 | 932 | 1.100 |
Why?
| | Life Expectancy | 2 | 2016 | 46 | 1.050 |
Why?
| | Directories as Topic | 1 | 2023 | 3 | 0.850 |
Why?
| | Insurance Carriers | 1 | 2023 | 9 | 0.840 |
Why?
| | Chronic Disease | 2 | 2019 | 1577 | 0.820 |
Why?
| | Risk Adjustment | 1 | 2022 | 76 | 0.760 |
Why?
| | Private Sector | 1 | 2020 | 51 | 0.690 |
Why?
| | Data Collection | 1 | 2023 | 618 | 0.690 |
Why?
| | Hospitals | 3 | 2022 | 581 | 0.660 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 224 | 0.660 |
Why?
| | Stillbirth | 1 | 2018 | 57 | 0.610 |
Why?
| | Guidelines as Topic | 1 | 2020 | 241 | 0.600 |
Why?
| | Cardiomyopathies | 1 | 2021 | 298 | 0.600 |
Why?
| | Statistics as Topic | 1 | 2018 | 291 | 0.580 |
Why?
| | Medicare | 2 | 2020 | 661 | 0.570 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 285 | 0.570 |
Why?
| | United States | 12 | 2023 | 12137 | 0.550 |
Why?
| | Physicians | 1 | 2023 | 765 | 0.480 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 675 | 0.420 |
Why?
| | Decision Making | 1 | 2018 | 760 | 0.400 |
Why?
| | Guideline Adherence | 1 | 2016 | 489 | 0.390 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1726 | 0.350 |
Why?
| | Child | 8 | 2022 | 18401 | 0.350 |
Why?
| | Asthma | 1 | 2022 | 2021 | 0.330 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1381 | 0.310 |
Why?
| | Percutaneous Coronary Intervention | 3 | 2020 | 445 | 0.290 |
Why?
| | Humans | 20 | 2023 | 114045 | 0.280 |
Why?
| | Child, Preschool | 4 | 2020 | 9114 | 0.250 |
Why?
| | Male | 12 | 2022 | 55396 | 0.250 |
Why?
| | Databases, Factual | 2 | 2020 | 1125 | 0.230 |
Why?
| | Female | 11 | 2022 | 59324 | 0.220 |
Why?
| | Shock, Cardiogenic | 1 | 2023 | 55 | 0.210 |
Why?
| | Data Accuracy | 1 | 2023 | 48 | 0.210 |
Why?
| | Sex Characteristics | 3 | 2016 | 636 | 0.190 |
Why?
| | Risk Factors | 4 | 2023 | 8614 | 0.190 |
Why?
| | Aged | 5 | 2022 | 18969 | 0.190 |
Why?
| | Hospital Units | 1 | 2021 | 23 | 0.190 |
Why?
| | Income | 1 | 2022 | 167 | 0.180 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4402 | 0.180 |
Why?
| | Adolescent | 6 | 2022 | 17800 | 0.180 |
Why?
| | Nutrition Surveys | 1 | 2022 | 225 | 0.180 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2021 | 148 | 0.170 |
Why?
| | Mitral Valve | 1 | 2020 | 94 | 0.160 |
Why?
| | Fibrosis | 1 | 2021 | 452 | 0.160 |
Why?
| | Hypoadrenocorticism, Familial | 1 | 2018 | 1 | 0.160 |
Why?
| | Aged, 80 and over | 3 | 2020 | 6306 | 0.160 |
Why?
| | Intensive Care Units | 1 | 2023 | 614 | 0.160 |
Why?
| | Retrospective Studies | 5 | 2023 | 12521 | 0.160 |
Why?
| | Hospitalization | 2 | 2019 | 1762 | 0.160 |
Why?
| | Infant, Newborn | 2 | 2020 | 5038 | 0.160 |
Why?
| | Young Adult | 4 | 2022 | 10444 | 0.150 |
Why?
| | Linear Models | 1 | 2020 | 768 | 0.150 |
Why?
| | Follow-Up Studies | 2 | 2016 | 4392 | 0.150 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2020 | 152 | 0.150 |
Why?
| | Age Factors | 3 | 2020 | 2885 | 0.140 |
Why?
| | Heart | 1 | 2021 | 613 | 0.140 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2020 | 175 | 0.140 |
Why?
| | Infant | 2 | 2020 | 7943 | 0.130 |
Why?
| | Federal Government | 1 | 2016 | 26 | 0.130 |
Why?
| | Middle Aged | 6 | 2023 | 26605 | 0.130 |
Why?
| | Return to Work | 1 | 2016 | 19 | 0.130 |
Why?
| | Length of Stay | 1 | 2020 | 957 | 0.130 |
Why?
| | Thrombolytic Therapy | 1 | 2016 | 117 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2021 | 756 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2016 | 146 | 0.120 |
Why?
| | Adult | 6 | 2023 | 30375 | 0.120 |
Why?
| | Prescription Drugs | 1 | 2016 | 116 | 0.120 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 286 | 0.110 |
Why?
| | Aspirin | 1 | 2016 | 324 | 0.110 |
Why?
| | Pediatrics | 1 | 2021 | 982 | 0.110 |
Why?
| | Survival Analysis | 1 | 2016 | 1206 | 0.110 |
Why?
| | Time Factors | 3 | 2018 | 6077 | 0.100 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2016 | 395 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2016 | 572 | 0.100 |
Why?
| | Recovery of Function | 1 | 2015 | 573 | 0.090 |
Why?
| | Risk Assessment | 1 | 2018 | 2958 | 0.080 |
Why?
| | Hospital Mortality | 2 | 2023 | 773 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2015 | 944 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2016 | 1815 | 0.060 |
Why?
| | Hospital Bed Capacity | 1 | 2021 | 22 | 0.050 |
Why?
| | Rural Health Services | 1 | 2021 | 92 | 0.040 |
Why?
| | Drug Substitution | 1 | 2016 | 46 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2016 | 172 | 0.030 |
Why?
| | Drug Industry | 1 | 2016 | 103 | 0.030 |
Why?
| | Perception | 1 | 2015 | 309 | 0.030 |
Why?
| | Critical Illness | 1 | 2016 | 640 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9049 | 0.020 |
Why?
| | Prospective Studies | 1 | 2015 | 6195 | 0.010 |
Why?
|
|
Bucholz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|